These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Antiscleroma effectiveness of certain Bacillus subtilis strains studied in vitro and in vivo.
    Author: Lysetska MV, Boiko NV.
    Journal: Mikrobiol Z; 2003; 65(5):13-9. PubMed ID: 14723157.
    Abstract:
    Antagonistic activity of approximately 200 Bacillus subtilis cultures vs. Klebsiella rhinoscleromatis clinical strains in experiments on solid and liquid nutrient media, and in experiments on laboratory animals has been studied. 16 B. subtilis strains characterized by a vivid antiscleroma activity in vivo have been selected. Maximum preventive and therapeutical influence of the B. subtilis strain 1119 upon the flow of experimental acute septic and lung scleroma infection has been determined. While co-cultivating the test cultures under study (B. subtilis 1119 and K. rhinoscleromatis 230), a significant titer decline and complete klebsiella's growth suppression on the 8th-12th days provided the certain concentrations of the antagonistic microbes have been shown.
    [Abstract] [Full Text] [Related] [New Search]